Federated Hermes
RVMD icon

Federated Hermes’s Revolution Medicines RVMD Stock Holding History

Federated Hermes’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,547
Closed -$126K – 2184
2023
Q3 		$126K Buy
+4,547
New +$135K ﹤0.01% 1577
2021
Q1 		– Sell
-21,933
Closed -$868K – 2335
2020
Q4 		$868K Buy
+21,933
New +$867K ﹤0.01% 1374

Other funds holding RVMD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Federated Hermes's RVMD Position: Q4 2023 in Review

Federated Hermes sold out of Revolution Medicines (RVMD) in Q4 2023, closing a stake of 4,547 shares — an estimated $126K sold.

Federated Hermes first reported a position in RVMD in Q4 2020 and held it in 2 quarters. The position peaked at $868K in Q4 2020. 184 funds tracked by Wall St. Rank hold RVMD as of Q4 2023.

  • Federated Hermes reported no remaining Revolution Medicines position as of Q4 2023 after selling out during the quarter.
  • Federated Hermes sold 4,547 Revolution Medicines shares in Q4 2023, an estimated $126K.
  • Federated Hermes first reported a position in Revolution Medicines in Q4 2020 and held it in 2 quarters.
  • Federated Hermes's Revolution Medicines position peaked at $868K in Q4 2020.
  • 184 funds tracked by Wall St. Rank held Revolution Medicines as of Q4 2023.

Based on Federated Hermes's 13F filing for Q4 2023, filed 31 Jan 2024.